Belén Valenzuela is a Consultant at SGS Exprimo. Belén obtained a Pharmacy degree with special excellence award from the University of Valencia in 1998 and her Pharm.D. degree from the same University in 2002. She also obtained a M.S. degree in Statistics for Health Sciences from the University of Barcelona in 2014. In 2002, Belén joined Pharmacy and Pharmaceutical Technology Area of the Miguel Hernandez University (UMH). She was the first full-time professor in this area and the Head of the Pharmacy and Pharmaceutical Technology Area for seven years. During this period, her research was focused on the population pharmacokinetic modelling applied to methadone, salbutamol, and antagonists of the TRPV1 channel. In 2009, Belén joined Quiron Torrevieja Hospital as Head of the Personalized Pharmacotherapy Service, inside the Platform of Oncology. In this position, she performed TDM and provided clinical support to the Clinical Oncology Department in order to personalize patient´s dosing schedule applying population PKPD models and simulations. In addition, she has performed population PKPD analysis of different oncology drugs under development. Her pharmacodynamic modelling experience is related to hematological, muscular and hepatic toxicities. Belén has been research co-director of 5 PhD Thesis successfully defended (University of Valencia and UMH). Belén joined SGS Exprimo in 2017 and lives in Alicante, Spain.